Publications

Exposure-response modelling for empagliflozin, a sodium glucose cotransporter 2 (sglt2) inhibitor, in patients with type 2 diabetes

M. M. Riggs, L. J. Seman, A. Staab, T. R. MacGregor, W. Gillespie, M. R. Gastonguay, H. J. Woerle, and S. Macha

Br J Clin Pharmacol

June 2014

External Link